A Pilot Study to Improve Patient-Doctor Communication
1 other identifier
interventional
106
1 country
1
Brief Summary
The purpose of this controlled pilot study is to determine whether an intervention aimed at patients will improve partnering, shared decision-making and open communication. Results from this pilot study will inform how to best proceed with a larger multi-centered randomized controlled trial. The specific hypothesis for this pilot study is to:
- 1.Test the feasibility of a simple patient-centered intervention.
- 2.Test the correlation between patient readiness to actively engage in conversation (assessed using a pre-visit patient survey) and actual patient behaviors in the encounter.
- 3.Develop a coding tool that will quantify patient activation in clinical encounters.
- 4.Test whether activating patients who are more involved and revealing in the patient-clinician dyad will improve patient and clinician outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 18, 2012
CompletedFirst Posted
Study publicly available on registry
May 28, 2012
CompletedMay 28, 2012
May 1, 2012
1 year
April 18, 2012
May 23, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Degree of shared medical decision-making
Assessed from transcribed audio-tapes of the doctor-patient encounter using Roter Interaction Analysis System (RIAS).
Baseline
Adherence to anti-hypertensive drug treatment at baseline
This outcome will be assessed using pill counts by the pharmacists.
Baseline
Adherence to anti-hypertensive drug treatment at one month
This outcome will be assessed using pill counts by the pharmacists.
One month
Adherence to anti-hypertensive drug treatment at three months
This outcome will be assessed using pill counts by the pharmacists.
Three months
Secondary Outcomes (8)
Patient satisfaction
Baseline
Clinician rating of patient as "difficult"
Baseline
Patient Trust in their physician at baseline
Baseline
Patient Trust in their physician at one month
one month
Patient Trust in their physician at three months
Three months
- +3 more secondary outcomes
Study Arms (2)
Usual Care Group
NO INTERVENTIONGroup will see their physician without receiving the "activation" instrument.
"Activated" Group
ACTIVE COMPARATORGroup will be given an "activation" instrument to complete before their appointment and instructed to refer to and use the instrument during their clinical encounter.
Interventions
The instrument is completed before the scheduled appointment and is designed to prompt patients to reflect on their specific goals for the medical encounter, prioritize those goals, and to "Prime" them to engage in a discussion centered on their concerns and expectations. In addition, participants will be encouraged to bring this form into their physician visit and use it to engage their clinician in a discussion about their health needs.
Eligibility Criteria
You may qualify if:
- Military health care beneficiaries presenting for chronic medical care with their primary care clinician
- Over the age of 18
- At least 2 and no more than 10 visits with their primary care provider in the previous year
- Receiving pharmacological treatment for hypertension
- At least 2 of the following common chronic illnesses: hyperlipidemia, chronic obstructive pulmonary disease, asthma, congestive heart failure, chronic pain, ischemic heart disease, osteoarthritis, depression, back pain, chronic headaches, or diabetes
You may not qualify if:
- Over the age of 80
- Incapable of completing the questionnaires, either due to cognitive impairment or lack of English-literacy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Walter Reed National Medical Military Center (WRNMMC)
Bethesda, Maryland, 20889, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick O'Malley, MD, MPH
Walter Reed National Military Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
April 18, 2012
First Posted
May 28, 2012
Study Start
November 1, 2010
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
May 28, 2012
Record last verified: 2012-05